Welcome to LookChem.com Sign In|Join Free
  • or
2-Chloromethyl-3-methyl-pyridine hydrochloride is a white crystalline chemical compound with the molecular formula C7H9Cl2N. It is widely used as a building block in the pharmaceutical industry for the synthesis of various drug molecules, including antihistamines, antipsychotic drugs, and anti-infective medications. Its versatile reactivity and valuable role in drug development make it an important compound in the chemical and pharmaceutical industries.

4370-22-3

Post Buying Request

4370-22-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4370-22-3 Usage

Uses

Used in Pharmaceutical Industry:
2-Chloromethyl-3-methyl-pyridine hydrochloride is used as a key intermediate in the synthesis of various pharmaceuticals for [application reason]. It contributes to the development of antihistamines, antipsychotic drugs, and anti-infective medications, playing a crucial role in addressing various health conditions.
Used in Agrochemical Industry:
In the agrochemical industry, 2-chloromethyl-3-methyl-pyridine hydrochloride is used as a building block for the production of pesticides. Its reactivity and versatility enable the creation of effective pest control agents, contributing to agricultural productivity and crop protection.
Used in Flavors and Fragrances Industry:
2-Chloromethyl-3-methyl-pyridine hydrochloride is also utilized in the manufacturing of flavors and fragrances. Its unique chemical properties allow for the development of novel scents and taste profiles, enhancing the sensory experience in various consumer products.

Check Digit Verification of cas no

The CAS Registry Mumber 4370-22-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,7 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4370-22:
(6*4)+(5*3)+(4*7)+(3*0)+(2*2)+(1*2)=73
73 % 10 = 3
So 4370-22-3 is a valid CAS Registry Number.

4370-22-3Relevant academic research and scientific papers

5-lipoxygenase-activating protein (FLAP) inhibitors. Part 4: Development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin- 2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor

Stock, Nicholas S.,Bain, Gretchen,Zunic, Jasmine,Li, Yiwei,Ziff, Jeannie,Roppe, Jeffrey,Santini, Angelina,Darlington, Janice,Prodanovich, Pat,King, Christopher D.,Baccei, Christopher,Lee, Catherine,Rong, Haojing,Chapman, Charles,Broadhead, Alex,Lorrain, Dan,Correa, Lucia,Hutchinson, John H.,Evans, Jilly F.,Prasit, Peppi

, p. 8013 - 8029 (2012/03/08)

The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2- ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11cc is described (AM803, now GSK2190915). Building upon AM103 (1) (Hutchinson et al. J. Med Chem.2009, 52, 5803-5815; Stock et al. Bioorg. Med. Chem. Lett. 2010, 20, 213-217; Stock et al. Bioorg. Med. Chem. Lett.2010, 20, 4598-4601), SAR studies centering around the pyridine moiety led to the discovery of compounds that exhibit significantly increased potency in a human whole blood assay measuring LTB4 inhibition with longer drug preincubation times (15 min vs 5 h). Further studies identified 11cc with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood (5 h incubation) and excellent preclinical toxicology and pharmacokinetics in rat and dog. 11cc also demonstrated an extended pharmacodynamic effect in a rodent bronchoalveolar lavage (BAL) model. This compound has successfully completed phase 1 clinical studies in healthy volunteers and is currently undergoing phase 2 trials in asthmatic patients.

NEUROLOGICALLY-ACTIVE COMPOUNDS

-

Page/Page column 58; 59, (2010/02/14)

Neurologically-active heterocyclic compounds comprising two fused 6-membered rings with nitrogen atoms at positions 1 and 3, a carboxy group at position 4,and a hydroxy group at position 8, with one ring being aromatic. Processes for the preparation of these compounds and their use as pharmaceutical or veterinary agents, in particular for the treatment of neurological conditions, and more specifically neurodegenerative conditions such as Alzheimer's disease.

Side Chain Chlorinations of N-Heterocyclic Compounds by Trichloroisocyanuric Acid (TCC)

Jeromin, Guenter E.,Orth, Winfried,Rapp, Bernd,Weiss, Wolfgang

, p. 649 - 652 (2007/10/02)

N-Heterocyclic compounds such as 2-methylpyridines, 2-methylquinoline, and 2-methylquinoxaline react with trichloroisocyanuric acid (TCC) without the addition of an initiator to provide the corresponding chloromethyl derivatives in good yields.

[1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles

-

, (2008/06/13)

Tricyclic ethers of the general formula I STR1 wherein R represents a bond and R1 represents a 1-2C-alkylene radical which is completely or partly substituted by fluorine, or a chlorotrifluoroethylene radical, or R and R1 each represent a difluoromethylene radical, R2 represents hydrogen or a 1-3C-alkyl radical, R3 represents hydrogen or a 1-3C-alkyl or 1-3C-alkoxy radical, R4 represents hydrogen or a 1-3C-alkyl radical and n represents the number 0 or 1, and their salts are new compounds with a marked protective effect on the stomach.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4370-22-3